2025 Bleeding Disorders Treatment Market Outlook: Key Indicators Shaping Growth Through 2034

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Will the Bleeding Disorders Treatment Industry Market Size Be by 2025?
The market for treating bleeding disorders has seen robust expansion in the past few years. The size of this market is forecasted to surge from $16.95 billion in 2024 to approximately $18.5 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.2%. Factors such as better patient knowledge, improved access to TH*Care services, advancements in the treatment of hemophilia, and widening of the global market have led to this observed growth during the historical period.

What's the Long-Term Growth Forecast for the Bleeding Disorders Treatment Market Size Through 2029?
It is projected that the market size of the treatment for bleeding disorders will significantly increase in the near future. The market's value is anticipated to reach $26.14 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 9.0%. The projected growth during the forecast period is due to factors such as the aging population, the rise of personalized medicine, patient advocacy, and support, an increase in disposable income, and greater expenditure on TH*Care. Some of the key trends to be seen in this period include the growth of personalized treatment plans, expansion of telehealth services, the use of advanced clotting factor therapies, rna-based treatments, and access to orphan drug designation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

What Are the Key Growth Drivers Fueling the Bleeding Disorders Treatment Market Expansion?
The surge in identified hemophilia cases is presumed to drive the growth of the bleeding disorders treatment market in the future. Hemophilia, a genetic disorder, prevents blood from clotting correctly. Its treatment involves replacement therapy, where the lacking or insufficient blood clotting factors are compensated by using human plasma concentrates or recombinant (created from DNA) forms of clotting factors VIII or IX. For instance, the World Federation of Hemophilia (WFH), a non-profit organization based in Canada, reported in 2022 that there were 257,146 hemophilia patients globally, comprising 208,957 with Hemophilia A and 42,203 with Hemophilia B. Consequently, the rise in diagnosed hemophilia patients is fuelling the expansion of the bleeding disorders treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7843&type=smp

What Are the Key Trends Driving Bleeding Disorders Treatment Market Growth?
Key players in the bleeding disorder treatment market are concentrating on the introduction of cutting-edge technologies such as single-dose treatments to boost the effectiveness of treatment and improve patient well-being by reducing the need for continuous therapies. A single-dose treatment uses a therapeutic method that gives a full treatment in one serving, targeting enduring effects without requiring multiple dosages. For example, BioMarin Pharmaceutical Inc., a biotechnology firm based in the US, unveiled BioMarin's ROCTAVIANTM (valoctocogene roxaparvovec-rvox) in June 2023. ROCTAVIAN is specifically developed for adults with severe hemophilia A (characterized as FVIII activity levels under 1 IU/dL) who lack pre-existing antibodies to adeno-associated virus serotype 5 (AAV5), as approved by an FDA-authorized test.

How Is the Bleeding Disorders Treatment Market Segmented?
The bleeding disorders treatment market covered in this report is segmented -

1) By Treatment: Desmopressin (DDAVP), Hormone Replacement Therapy, Contraceptives, Anti-Fibrinolytic or Clot-Stabilizing Drugs, Fibrin Sealants, Drugs Applied To Cuts, Pipeline Analysis
2) By Disease Type: Hemophilia A, Hemophilia B, Von Willebrand disease, Liver disease, Other Disease Types
3) By End User: Hospitals, Clinics, Specialty Clinics, Research Institutes, Other End Users

Subsegments:
1) By Desmopressin (DDAVP): Intravenous Formulations, Nasal Spray Formulations
2) By Hormone Replacement Therapy: Estrogen Therapy, Progesterone Therapy
3) By Contraceptives: Combined Oral Contraceptives, Progestin-Only Contraceptives
4) By Anti-Fibrinolytic or Clot-Stabilizing Drugs: Tranexamic Acid, Aminocaproic Acid
5) By Fibrin Sealants: Tisseel, Artiss
6) By Drugs Applied To Cuts: Antiseptics, Topical Hemostatic Agents
7) By Pipeline Analysis: Upcoming Treatments in Development, Novel Therapeutics and Technologies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7843&type=smp

Which Companies Are Leading the Charge in Bleeding Disorders Treatment Market Innovation?
Major companies operating in the bleeding disorders treatment market include AbbVie Inc., Bayer AG, Novo Nordisk A/S, Pfizer Inc., Biogen Inc., CSL Behring Company, Grifols SA, Octapharma AG, BDI Pharma Inc., Ferring Pharmaceuticals Ltd., Xenetic Biosciences Inc., Sanofi SA, Alnylam Pharmaceuticals Inc., Novartis AG, Shire plc, Novo Nordisk, Grifols SA, F. Hoffmann-La Roche AG, Sanofi Corporation, Takeda Pharmaceutical Company Limited, Kedrion S.p.A, Biotest AG, LFB S.A, Emergent BioSolutions Inc., Bio Products Laboratory Ltd., HEMA Biologics LLC, ADMA Biologics Inc., Grifols Biologicals Inc., Octapharma Plasma Inc., Kedrion Biopharma Inc., BPL Plasma Inc., BioLife Plasma Services, CSL Plasma Ltd., Grifols Shared Services North America Inc., Octapharma USA Inc., Shire US Inc., Pfizer Canada Inc., Grifols Canada Ltd., Octapharma Canada Inc.

Which Regions Are Leading the Global Bleeding Disorders Treatment Market in Revenue?
North America was the largest region in the bleeding disorders treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bleeding disorders treatment market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7843

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.